Antibodies against a secreted protein from hookworm larvae reduce the intensity of hookworm infection in humans and vaccinated laboratory animals


Bethony, J; Loukas, A; Smout, M; Brooker, S; Mendez, S; Plieskatt, J; Goud, G; Bottazzi, ME; Zhan, B; Wang, Y; Williamson, A; Lustigman, S; Correa-Oliveira, R; Xiao, SH; Hotez, PJ; (2005) Antibodies against a secreted protein from hookworm larvae reduce the intensity of hookworm infection in humans and vaccinated laboratory animals. FASEB journal , 19 (9). ISSN 0892-6638 DOI: 10.1096/fj.05-3936fje

Full text not available from this repository.

Abstract

The development of a vaccine would provide an important new tool for the control of human hookworm infection. On the basis of successful vaccination of laboratory animals with living irradiated, third-stage hookworm larvae (L3), we examined the antibody responses of individuals from hookworm endemic areas of Brazil and China against the most abundant L3 secreted antigens, the ancylostoma secreted proteins, ASP-1 and ASP-2. Logistic regression was used to investigate the effects of antibody isotype responses to ASPs on the risk of an individual harboring heavy hookworm infection. A significant protective association was observed between increasing anti-ASP-2 IgE levels and the risk of heavy hookworm infection. To confirm that ASP-2 is a protective antigen, laboratory dogs were immunized with recombinant ASP-2 formulated with the GlaxoSmithKline Adjuvant, AS03. Sera obtained from the immunized dogs exhibited high geometric mean antibody titers, immunoprecipitated native ASP-2 from L3 extracts and localized the site of ASP-2 expression to the glandular esophagus and body channels exiting to the cuticle. The sera also exhibited an increased ability to inhibit migration of L3 through tissue in vitro relative to sera from AS03-injected controls. Upon L3 challenge, the ASP-2 vaccinated dogs exhibited significant reductions in fecal egg counts and intestinal hookworm burden. These findings provide strong support for the development of an effective recombinant vaccine against hookworm infection in humans.

Item Type: Article
Keywords: ancylostoma secreted proteins, morbidity reduction, vaccine, Transmitted helminth infections, ancylostoma-caninum, necator-americanus, endemic area, onchocerca-volvulus, molecular-cloning, family, schistosomiasis, mebendazole, expression
Faculty and Department: Faculty of Infectious and Tropical Diseases > Dept of Disease Control
Research Centre: Vaccine Centre
PubMed ID: 16037096
Web of Science ID: 230923000014
URI: http://researchonline.lshtm.ac.uk/id/eprint/13233

Statistics


Download activity - last 12 months
Downloads since deposit
0Downloads
316Hits
Accesses by country - last 12 months
Accesses by referrer - last 12 months
Impact and interest
Additional statistics for this record are available via IRStats2

Actions (login required)

Edit Item Edit Item